<?xml version="1.0" encoding="UTF-8"?>
<p>Eosinophils are conducive to IAV infection and undergo piecemeal degranulation in response to IAV [
 <xref rid="B160" ref-type="bibr">160</xref>]. This selective release of granule proteins such as major basic protein, eosinophil peroxidase, eosinophil cationic protein, and eosinophil-derived neurotoxin, in addition to immunoregulatory cytokines and chemokines [
 <xref rid="B161" ref-type="bibr">161</xref>, 
 <xref rid="B162" ref-type="bibr">162</xref>] at the infection site, may either immunomodulate other leukocytes or help contain the virus 
 <italic>in situ</italic> (
 <xref ref-type="fig" rid="fig3">Figure 3</xref>). Additionally, mice suffering from acute allergy are protected from IAV-induced airway damage [
 <xref rid="B157" ref-type="bibr">157</xref>] suggesting that eosinophils are important mediators during anti-influenza immunity in special populations of patients such as those with a T
 <sub>H</sub>2 bias. Our findings that eosinophils were capable of trafficking to DLNs following IAV infection and their putative function in IAV antigen presentation in the context of MHCI to activate CD8
 <sup>+</sup> T cells [
 <xref rid="B160" ref-type="bibr">160</xref>] forecast multifaceted functions for eosinophils during influenza pathogenesis [
 <xref rid="B163" ref-type="bibr">163</xref>].
</p>
